The drugs, which include cancer and other critical-care medications, are currently in short supply, causing many hospitals to ration them or look to “gray market” distributors who have obtained the drugs and are willing to resell them to hospitals at a profit. A survey in August by Premier healthcare alliance found the average markup of these drugs was 650 percent, according to the report.
Rep. Cummings sent document request to five privately held drug distributors seeking information on the prices they paid for the drugs and the markup rate, according to the report.
Related Articles on Drug Distributors:
8 Steps to Ensuring Safe, Reliable Medication Purchases During Drug Shortages
52% of Hospitals, Pharmacists Buy Drugs From “Gray Market”
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
